Clinical Trial Update: Dehydroepiandrosterone (DHEA) + Acolbifene Against Vasomotor Symptoms (Hot Flushes) in Postmenopausal Women [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating dehydroepiandrosterone (DHEA) plus acolbifene for vasomotor symptoms (hot flashes) in postmenopausal women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause-related Vasomotor Symptoms

Drugs mentioned

• Acolbifene (acolbifene)
• Dehydroepiandrosterone (dehydroepiandrosterone)

Snippet

Sponsor: EndoCeutics Inc. | Conditions: Vasomotor Symptoms, Hot Flushes | Phase 3 | Status: COMPLETED